Cargando…

Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda

Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Karger, Erik, Kureljusic, Marko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785219/
https://www.ncbi.nlm.nih.gov/pubmed/36558943
http://dx.doi.org/10.3390/ph15121492
_version_ 1784857995801264128
author Karger, Erik
Kureljusic, Marko
author_facet Karger, Erik
Kureljusic, Marko
author_sort Karger, Erik
collection PubMed
description Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Nevertheless, so far, no study takes a holistic view of AI-based drug discovery research. Given the importance and potential of AI for drug discovery, this lack of research is surprising. This study aimed to close this research gap by conducting a bibliometric analysis to identify all relevant studies and to analyze interrelationships among algorithms, institutions, countries, and funding sponsors. For this purpose, a sample of 3884 articles was examined bibliometrically, including studies from 1991 to 2022. We utilized various qualitative and quantitative methods, such as performance analysis, science mapping, and thematic analysis. Based on these findings, we furthermore developed a research agenda that aims to serve as a foundation for future researchers.
format Online
Article
Text
id pubmed-9785219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-97852192022-12-24 Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda Karger, Erik Kureljusic, Marko Pharmaceuticals (Basel) Article Drug discovery is usually a rule-based process that is carefully carried out by pharmacists. However, a new trend is emerging in research and practice where artificial intelligence is being used for drug discovery to increase efficiency or to develop new drugs for previously untreatable diseases. Nevertheless, so far, no study takes a holistic view of AI-based drug discovery research. Given the importance and potential of AI for drug discovery, this lack of research is surprising. This study aimed to close this research gap by conducting a bibliometric analysis to identify all relevant studies and to analyze interrelationships among algorithms, institutions, countries, and funding sponsors. For this purpose, a sample of 3884 articles was examined bibliometrically, including studies from 1991 to 2022. We utilized various qualitative and quantitative methods, such as performance analysis, science mapping, and thematic analysis. Based on these findings, we furthermore developed a research agenda that aims to serve as a foundation for future researchers. MDPI 2022-11-30 /pmc/articles/PMC9785219/ /pubmed/36558943 http://dx.doi.org/10.3390/ph15121492 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Karger, Erik
Kureljusic, Marko
Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title_full Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title_fullStr Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title_full_unstemmed Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title_short Using Artificial Intelligence for Drug Discovery: A Bibliometric Study and Future Research Agenda
title_sort using artificial intelligence for drug discovery: a bibliometric study and future research agenda
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9785219/
https://www.ncbi.nlm.nih.gov/pubmed/36558943
http://dx.doi.org/10.3390/ph15121492
work_keys_str_mv AT kargererik usingartificialintelligencefordrugdiscoveryabibliometricstudyandfutureresearchagenda
AT kureljusicmarko usingartificialintelligencefordrugdiscoveryabibliometricstudyandfutureresearchagenda